Evidence map›Paper›PMID 26903790›Full record

ArticleFrontiers in neuroscience2016

Glucocorticoid Regulation of Food-Choice Behavior in Humans: Evidence from Cushing's Syndrome.

Scott J Moeller, Lizette Couto, Vanessa Cohen, Yelena Lalazar, Iouri Makotkine, Nia Williams, Rachel Yehuda, Rita Z Goldstein, Eliza B Geer

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neuroscience, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. The Metabolic Syndrome, a Human Disease.International journal of molecular sciences · 2024
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Scott J MoellerDepartment of Psychiatry, Icahn School of Medicine at Mount SinaiNew York, NY, USA; Department of Neuroscience, Icahn School of Medicine at Mount SinaiNew York, NY, USA.
Lizette CoutoDepartment of Medicine, Icahn School of Medicine at Mount SinaiNew York, NY, USA; Department of Neurosurgery, Icahn School of Medicine at Mount SinaiNew York, NY, USA.
Vanessa CohenDepartment of Medicine, Icahn School of Medicine at Mount SinaiNew York, NY, USA; Department of Neurosurgery, Icahn School of Medicine at Mount SinaiNew York, NY, USA.
Yelena LalazarDepartment of Medicine, Icahn School of Medicine at Mount SinaiNew York, NY, USA; Department of Neurosurgery, Icahn School of Medicine at Mount SinaiNew York, NY, USA.
Iouri MakotkineDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai New York, NY, USA.
Nia WilliamsDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai New York, NY, USA.
Rachel YehudaDepartment of Psychiatry, Icahn School of Medicine at Mount SinaiNew York, NY, USA; Department of Neuroscience, Icahn School of Medicine at Mount SinaiNew York, NY, USA.
Rita Z GoldsteinDepartment of Psychiatry, Icahn School of Medicine at Mount SinaiNew York, NY, USA; Department of Neuroscience, Icahn School of Medicine at Mount SinaiNew York, NY, USA.
Eliza B GeerDepartment of Medicine, Icahn School of Medicine at Mount SinaiNew York, NY, USA; Department of Neurosurgery, Icahn School of Medicine at Mount SinaiNew York, NY, USA.
Icahn School of Medicine at Mount Sinai · US

Funding

MSHS Translational Science HubUL1TR001433 · NCATS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI WRIGHT, ROSALIND J · 2015 to 2019
$26.6M
Mount Sinai Institutes for Clinical and Translational SciencesUL1TR000067 · NCATS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI SAMPSON, HUGH A · 2012 to 2014
$16.5M
Genetic markers associated with brain structural abnormalities and drug use in human addictionK01DA037452 · NIDA · STATE UNIVERSITY NEW YORK STONY BROOK · PI MOELLER, SCOTT J · 2015 to 2019
$778k
Body Composition and the Metabolic Syndrome in Cushing's DiseaseK23DK082617 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI GEER, ELIZA BREVOORT · 2008 to 2012
$751k
NCATS NIH HHS UL1 TR000067NCATS NIH HHS UL1 TR001433NIDA NIH HHS K01 DA037452NIDDK NIH HHS K23 DK082617
6 · The paper itself

Abstract

The mechanisms by which glucocorticoids regulate food intake and resulting body mass in humans are not well-understood. One potential mechanism could involve modulation of reward processing, but human stress models examining effects of glucocorticoids on behavior contain important confounds. Here, we studied individuals with Cushing's syndrome, a rare endocrine disorder characterized by chronic excess endogenous glucocorticoids. Twenty-three patients with Cushing's syndrome (13 with active disease; 10 with disease in remission) and 15 controls with a comparably high body mass index (BMI) completed two simulated food-choice tasks (one with "explicit" task contingencies and one with "probabilistic" task contingencies), during which they indicated their objective preference for viewing high calorie food images vs. standardized pleasant, unpleasant, and neutral images. All participants also completed measures of food craving, and approximately half of the participants provided 24-h urine samples for assessment of cortisol and cortisone concentrations. Results showed that on the explicit task (but not the probabilistic task), participants with active Cushing's syndrome made fewer food-related choices than participants with Cushing's syndrome in remission, who in turn made fewer food-related choices than overweight controls. Corroborating this group effect, higher urine cortisone was negatively correlated with food-related choice in the subsample of all participants for whom these data were available. On the probabilistic task, despite a lack of group differences, higher food-related choice correlated with higher state and trait food craving in active Cushing's patients. Taken together, relative to overweight controls, Cushing's patients, particularly those with active disease, displayed a reduced vigor of responding for food rewards that was presumably attributable to glucocorticoid abnormalities. Beyond Cushing's, these results may have relevance for elucidating glucocorticoid contributions to food-seeking behavior, enhancing mechanistic understanding of weight fluctuations associated with oral glucocorticoid therapy and/or chronic stress, and informing the neurobiology of neuropsychiatric conditions marked by abnormal cortisol dynamics (e.g., major depression, Alzheimer's disease).

Indexed as

choice behaviorcortisolCushing's syndromedecision-makingfood cravingglucocorticoidsreward processing

Identifiers

PMID26903790
PMCPMC4742561
OpenAlexW2280444625

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.